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SCHEDULE FOR THE ADOPTION PROCESS OF DOCUMENT QAS

83
Category. Diagnostic.
85
Storage. Labelling. The label complies with the General monograph, the monograph of Radiopharmaceuticals.
92
The label includes the name stabilizer if added. Impurity C. Carry out the test described under 1.14.1 Thin-layer chromatography for impurity C use
153
TLC silica gel plate R, a glass fiber plate and 9 g/L solution of sodium chloride as a mobile phase.
154
Apply to the plate about 5 µl of the injection to be examined and develop immediately for a distance Not less than 80% of the total technetium-99m radioactivity is present as lipophilic technetium-99m 172 exametazime and impurity A. retention with reference to lipophilic technetium-99m exametazime to impurity A is about 1.2.
186
The produced chromatogram is similar to the chromatogram provided with meso-rich exametazime
187
CRS. The resolution is minimum of 2 between the peaks due to lipophilic technetium-99m 188 exametazime and to impurity A. Impurity A should not more than 5% of the radioactivity due to 189 lipophilic technetium-99m exametazime and impurity A. the test solution is not greater than that of the reference solution; not more than 0.6 µg of Sn per ml.
201
Radioactivity. Measure the radioactivity using a suitable instrument as described under R. 
